(Date:12/1/2009)...c. 1 Reportlinker.com announces th...s catalogue: ,, Emerging Clinical Trial Locati...ging healthcare and regulatory environment ,, ...nical-Trial-Locations---Eastern-Europe-Market-dyna...vironment.html ,, Over the last decade pharmac...
(Date:12/1/2009)...ty Leader Richard Gephardt Brings Together A-List ...nities for "Best and Brightest Forum on Medical I...wswire-USNewswire/ -- Several of New Jersey,s most..., medicine and technology gathered today at the Li...medical innovation in New Jersey, and throughout t...
(Date:12/1/2009)...l., Dec. 1 Prairie Heart Institute...was recently awarded two statuettes at the first-e... York City. The CLIO Healthcare Awards recognizes ...re advertising industry and is an extension of the...wards competitions for advertising, design and int...
(Date:12/1/2009)...ax, Inc. today announced a collaborative research ...aimed at evaluating EpiVax’s proprietary Tre...detrimental immune responses to certain drugs. In ...EpiVax Tregitope technology will be evaluated for ...apeutics. , (Vocus) Decem...
Breaking Biology Technology:Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 2Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 3Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 4Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 5Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 6Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 7Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 8New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 2New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 3New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 4New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 5Prairie Heart Institute of Illinois Wins Two CLIO Healthcare Awards 2EpiVax, Inc. forms Collaborative Research Agreement with Roche to Develop Tregitope Technology 2EpiVax, Inc. forms Collaborative Research Agreement with Roche to Develop Tregitope Technology 3(Date:12/1/2009)...unce the publication of results from its Phase II ...rability of its novel, intranasal drug/device prod...sitis with nasal polyps in Rhinology , the offici...logic Societies. , Chronic rhinosinusitis with ...cantly reduce a patient,s quality of life, causing...
(Date:12/1/2009)...researchers have developed a tumor-attacking viru... growth of new tumor blood vessels. , Their rese...lls oncolytic viruses might be more effective ag... gene for a protein that inhibits blood-vessel gro...ally produced in the brain. In this study, an onco...
(Date:12/1/2009)...rks can be solved with a new technique that identi...their victims, according to a University of Florid...logous to analyzing human fingerprints, scientists...hark bites to the jaws and teeth of the powerful p...ernational Shark Attack File, which is housed at U...
Breaking Biology News(10 mins):New data on highly effective treatment for chronic rhinosinusitis with nasal polyps 2Tumor-attacking virus strikes with 'one-two punch' 2New forensic technique gives clues about sharks from bite damage 2New forensic technique gives clues about sharks from bite damage 3Caraco Pharmaceutical Laboratories Ltd Markets Nicardipine Hydrochloride Injection 6376 1Caraco Pharmaceutical Laboratories Ltd Markets Nicardipine Hydrochloride Injection 6376 2Cancers sweet tooth may be weakness 10788 1Cancers sweet tooth may be weakness 10788 2HCA Names Joe Sowell Senior Vice President 26amp 3B Chief Development Officer 61620 1HCA Names Joe Sowell Senior Vice President 26amp 3B Chief Development Officer 61620 2Mouse Anti-Kusabira Orange Monoclonal Antibody, Unconjugated, Clone 2G9 from MBL International
Goat Anti-SPFH2 Polyclonal Antibody, Unconjugated from Abcam
Goat Anti-Als2 Polyclonal Antibody, Unconjugated from Abcam
Mouse Anti-Kusabira Orange Monoclonal Antibody, Unconjugated, Clone 2G9 from MBL International
Biology Products: